ACRIN Research Associates Educational Session Radiation Therapy Oncology Group Research Associates Committee Joyce Neading, RHIT, CTR Program Director,

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Commission on Cancer Mission
UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.
0 EMS Stakeholders Meeting 2011 August 25, 2011 Bob Leopold EMS and Trauma Systems Program.
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.
GASP Vision The Georgia Association of Sleep Professionals is the leader in Georgia for setting standards and promoting excellence in sleep medicine care,
POST APPROVAL MONITORING AND EDUCATION PROGRAM Jane Lehmbeck 1, Sarah Blackman 1, Karen Davenport 2, Karen Parks 1 Office of the Vice President for Research.
Norris Cotton Cancer Center Global Update CTOP RETREAT May 2014.
COMMISSIONED OFFICER VACANCY ANNOUNCEMENT NEW YORK AIR NATIONAL GUARD 174th FIGHTER WING 6001 EAST MOLLOY ROAD SYRACUSE, NY ANNOUNCEMENT DATE:
Nurse Staffing in New Hampshire Implementing a Nurse Staffing Committee NH Staffing Toolkit July 2010.
Strategic Alliances: The Vital Link Between the National Association for Health Care Recruitment and the State Chapters Terry Bennett, RN, MS, CHCR Director.
CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.
Sunflower Chapter HFMA Sunflower Chapter Leadership  President: Angela Miratsky  President-Elect: Ashley Simon-Clifton  Vice President:
Roles & Responsibilities
ISCB-SC - Saraswathi.S Saraswathi S PhD Student Iowa State University Ames, Iowa, USA Chairperson: ISCB-SC-RSG.
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
2011 ACRIN Annual Meeting ACRIN ACCELERATED ACCRUAL DEMONSTRATION PROJECT Department of Radiology The University of Iowa Carol Mertens, Ph.D., CFLE, LMHC.
New IRB Guideline Changes and Converting to eIRB - Suggestions for Maintaining Compliance. Ramesh Ghodgaonkar, BPHARM, MSITS, MSB, MBA Betsy Johnson, BA.
Developing Relationships: Cooperative Group Networking Developing Relationships: Cooperative Group Networking Kandie Dempsey, MS, RN, OCN, CCRP Delaware.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Risk Management, Assessment and Planning Committee III-4.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
Minimum Standards and Exemplary Attributes of Clinical Trial Sites S. Gail Eckhardt, MD (Slides prepared by Robin Zon, MD)
Oncology Nursing Society Forming a new CHIP at the local level.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
CENTRAL IRBS Human Subjects Working Group Meeting May 8, 2008 Betsy Ellis and Becky Hawkins.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
Serve the Professional, Advance the Profession SHRM Student Member Benefits Presented by SHRM Student Programs Updated April 2007.
The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Systems Accreditation Berkeley County School District School Facilitator Training October 7, 2014 Dr. Rodney Thompson Superintendent.
Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Hiring a Nurse Researcher/Scientist Nursing Research Field Advisory Committee (NRFAC) January 2015.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
NASCE: Programme requirements Paul Ridgway. Need for NASCE? Cost of Skills training Pressures for training outside service hours Pressures for training.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
SARC Individual and Institutional Participation 2013.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
AccrualNet: A New NCI Tool for Supporting Accrual to Clinical Trials Linda Parreco, RN, MS NCI, Office of Communication and Education September 29, 2010.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
NCCCP Pilot – Clinical Trials Ann O’Mara, PhD, RN, FAAN Program Director Community Clinical Oncology Program Division of Cancer Prevention June 26, 2007.
ACRIN CV Committee ACRIN PDRC ACRIN PA 4008 Protocol and Regulatory Requirements Patricia Atkinson, Quality Control Monitor.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
11 Radiation Therapy Oncology Group Clinical Trials Administration Sharon Hartson Stine, Director Group Administrator.
BRITTANY HAGEN BS RN OCN CCRC CLINICAL RESEARCH MANAGER OHC, INC. OHC Research.
Responsibilities of Sponsor, Investigator and Monitor
Omega Best Cancer Hospital - India
NMHIMSS Meet the Board & Committees May 26th, 2016
Responsibilities of Sponsor, Investigator and Monitor
The Essentia Institute of Rural Health (EIRH) is
University Career Services Committee
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
National audit of adult IBD service provision
NIH Clinical Trial Requirements
MUHC Innovation Model.
Bozeman Health Clinical Research
Nominations Needed for the Ballot
Roles & Responsibilities
Clinical Trial Development: NRG Processes and NCI Requirements
Position descriptions
Presentation transcript:

ACRIN Research Associates Educational Session Radiation Therapy Oncology Group Research Associates Committee Joyce Neading, RHIT, CTR Program Director, Cancer Research and Registry Summa Health System Hospitals Akron, Ohio

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group History  Organized in 1968 under the direction of Dr. Simon Kramer  A national clinical cooperative group  Purpose of conducting radiation therapy research and cooperative clinical investigations  NCI funding began in 1971  First study activated was adjuvant methotrexate study for advanced head and neck cancer enrolled over 700 patients  A milestone in multidisciplinary clinical research

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Objectives  Increase survival in patients with malignant diseases  Demonstrate the contributions of new modalities for treatment  Improve the quality of life of cancer patients  Prevent second and subsequent malignancies in patients cured of cancer  Seek greater understanding of the biology of cancer

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Membership  Full Member Institutions – 37 Active  Personnel Required: 3 full-time radiation oncologists, 1 staff radiotherapist/ new patients treated per year, 1 full-time Board-certified Physicist, research staff  Equipment Required: 2 megavoltage units with at least one unit for every 300 new cancer patients treated each year with capability of obtaining field areas of 35 cm x 35 cm, diagnostic quality for localization and simulation, treatment planning system capable of generating isodose distribution  Fifty percent of patients should be considered curable  Institutional Review Board (IRB) and Federal Wide Assurance (FWA) approved by Office for Human Research Protections (OHRP)

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Membership  Affiliate (234 active) and CCOP (33 active) members  Personnel Required: 1 full-time radiation oncologist, 1 staff radiotherapist/200 to 225 new patient treated per year, a part-time physicist, ability to handle data management, representation of medical oncology, surgery and pathology with commitment of full-time people to participate in RTOG  Equipment Required: 1 megavoltage unit with capability of obtaining field areas of 35 cm x 35 cm, diagnostic quality for localization and simulation, treatment planning section able to plan and implement radiotherapy techniques, access to computer for treatment planning dosimetry  Minimum of 250 to 300 new patients treated per year  Institutional Review Board (IRB) and Federal Wide Assurance (FWA) approved by Office for Human Research Protections (OHRP)

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Annual Accrual Requirements  Full Member – 25 treatment and/or cancer control credits  Affiliate Member – 5 treatment and/or cancer control credits  CCOP – 10 treatment and/or cancer control credits

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Organization Group Chair Oversight CommitteesScientific Core Committees Disease Site Committees and Working Groups

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Committees – Oversight Committees  Data Monitoring  Patient Advocacy  CCOP Membership  Quality Control  Research Strategy  Executive  New Investigators  Research Associates *  Publications  Nominating  Steering  Membership Evaluation

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Committees – Scientific Core Committees  Advanced Technology Integration  Medical Physics  Pathology  Translational Research Program  Medical Oncology  Health Services Research and Outcomes  Surgical Oncology

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Committees – Disease Site Committees and Working Groups  Brain Tumor  Gastrointestinal Cancer  Gynecologic Cancer Working Group  Lung Cancer  Breast Cancer Working Group  Genitourinary Cancer  Head and Neck Cancer  Sarcoma Working Group

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee  Research Associates Committee formed in 1984  Purpose – to represent the interests of research associates in the Radiation Therapy Oncology Group  Mission – each committee of the Radiation Therapy Oncology Group will have a research associate member to represent the research associates’ perspective as well as act as a liaison between the RTOG committee and the Research Associates Committee to facilitate the conduct of studies

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee Organization Chair Co-Chair Secretary Membership Chair Education Committee Research Strategy Poster Contest Disease Discipline Quality Control Headquarters Mentor Committee Communications

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committees – Function  Chair presides over the Research Associates Steering Committee and the Research Associates Committee and meetings  Co-chair assists the chair with conduct of meetings, co-chair functions as chair in absence of chair  Secretary records minutes of meetings  Membership chair maintains a database of Research Associates Committee members with contact information

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Education Committee  Education Committee plans and develops the Research Associate Panel Discussion and Research Associates Scientific Session  Determine subject matter based on needs assessment  Recruit speakers  Apply for continuing education credits for nurses and research associates  Chair and co-chair introduce speakers and moderate program  Collect evaluation forms and distribute CE certificates

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Research Strategy  RA Research Strategy Committee was formed to offer research associates the opportunity and forum to conduct clinical research; be a principal investigator  Research associates develop concepts for supportive care or intervention protocols  The first RA protocol using Biafine cream in breast cancer patients receiving radiotherapy was published and presented at ASTRO in 2005  Another protocol using Biafine cream in head and neck patients receiving radiotherapy was published in 2006  The Committee has two concepts in development; acidophilus to reduce thrush in head and neck cancer patients receiving RT +/- chemotherapy and Linde serum for cetuximab induced rash

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Disease Discipline  Members of Disease Discipline are assigned to the Disease Site Committees and Working Groups to represent the concerns of the research associates at RTOG meetings  Protocols in development are reviewed by the research associate assigned to determine feasibility of the study and its conduct in RTOG institutions  Developed an Acuity Tool to determine the complexity of each trial reviewed

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Quality Control  A research associate sits as a member of the RTOG Quality Control Committee  Areas of deficiencies found at time of audit are discussed  The research associate member reports concerns of Quality Control regarding deficiencies to the Research Associates Committee  The member meets with the Education Committee who develop programs to educate research associates in ways to prevent deficiencies and improve data quality

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Poster Contest  Research associates are invited to participate in the Poster Contest held at the summer RTOG meeting  The Poster Contest Committee recruits poster presenters and coordinates the contest  Posters are displayed  Judges score the posters and determine a winner  The winner is announced at the RTOG business meeting  Winner is awarded $750 travel voucher to any educational meeting

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Headquarters  RTOG Headquarters assigns a member to the Research Associates Committee  Representative updates the Research Associates Committee about activities at Headquarters  Concerns and questions of research associates are taken to Headquarters by the representative member for resolution  Headquarters representative offers educational opportunities to the Education Committee and the Research Associates Committee as a whole

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Mentor Committee  Established by RTOG Membership Evaluation Committee  Purpose: assist any institution with Membership Evaluation scores that are unacceptable, i.e. <80%  Assist with audit preparation, cleaning up data, educating staff, help PI assess staffing levels and develop action plans  Qualifications: > 5 years experience from full member institution or affiliate institution entering cases/year; acceptable data quality scores and site visits, approval from home institution and approval by HQ data management staff and/or audit staff

Summa Health System, Akron, Ohio Radiation Therapy Oncology Group Research Associates Committee – Function of Communications Committee  Communications Committee coordinates publication of the RA Reporter  Recruit writers and articles  Writes articles  Photographs events at RTOG semiannual meetings for publication in the newsletter  Work with RTOG Headquarters to publish the newsletter and post it on the RTOG webpage

Summa Health System, Akron, Ohio Any Questions?